South-Korea Dental Soft-Tissue Regeneration Market Size, Share,Trends, Growth Analysis Report, 2029

Name: South-Korea Dental Soft-Tissue Regeneration Market Size, Share,Trends, Growth Analysis Report, 2029
Creator: MarketsandMarkets

Overview Request Sample Pages Request Customization Download PDF

You are viewing: South Korea Dental Soft-Tissue Regeneration Market analysis

Part of: Dental Soft-Tissue Regeneration Market (Global)

The South Korea Dental Soft-Tissue Regeneration Market was valued at $6.43 Million in 2024 and projected to reach to $10.24 Million by 2029, representing a compound annual growth rate of 9.8%. South Korea's dental soft-tissue regeneration market is positioned for sustained expansion, driven by demographic shifts and technological advancement.

South Korea Dental Soft-Tissue Regeneration Market (2024-2029) : Size and Share

CAGR of

USD Million

South Korea Dental Soft-Tissue Regeneration Market Trends and Insights

This 9.8% compound annual growth rate reflects South Korea's advanced healthcare infrastructure and rising demand for minimally invasive periodontal treatments.
South Korea's aging population and increasing prevalence of periodontal disease are driving adoption of regenerative dental solutions among both patients and practitioners. The South Korea market benefits from strong government healthcare support, high dental care awareness, and significant investment in biotechnology innovation.
South Korea's position as a leader in medical device manufacturing and cosmetic dentistry creates favorable conditions for soft-tissue regeneration product adoption.
By 2029, South Korea is expected to solidify its role as a key Asia Pacific hub for dental regenerative therapies, supported by clinical research initiatives and growing patient preference for tissue-preserving procedures..

Key Market Statistics

CAGR (2024-2029) 9.8% CAGR
Market Size, 2024 ~USD 6.43 Million
Forecast, 2029 ~USD 10.24 Million
Country South Korea

South Korea Dental Soft-Tissue Regeneration Market Overview

Market Valuation & Growth :

South Korea's dental soft-tissue regeneration market reached $6.43 million in 2024, with a robust 9.8% CAGR projected through 2029, outpacing the global average of 7.8%.

Aging Population Dynamics :

South Korea's rapidly aging demographic is driving increased demand for advanced periodontal treatments, with seniors seeking minimally invasive solutions for gum disease and tissue loss.

Advanced Healthcare Infrastructure :

South Korea's world-class dental technology adoption and high healthcare spending per capita create an ideal environment for premium soft-tissue regeneration products and services.

Minimally Invasive Treatment Preference :

South Korean patients and practitioners increasingly favor regenerative periodontal procedures over traditional invasive methods, driving market expansion and innovation in biomaterial solutions.

South Korea Dental Soft-Tissue Regeneration Market Dynamics

The country's aging population, combined with rising disposable incomes and healthcare awareness, creates strong demand for innovative periodontal treatments.
South Korea's reputation as a healthcare innovation hub supports rapid adoption of cutting-edge regenerative technologies. The market's 9.8% CAGR reflects growing investment in dental biotechnology and increasing patient preference for minimally invasive procedures.
Strategic partnerships between Korean dental manufacturers and international players, coupled with supportive regulatory frameworks, will accelerate market penetration.
By 2029, the market is expected to reach $10.24 million, establishing South Korea as a key regional hub for soft-tissue regeneration solutions in Asia-Pacific..

Related Ecosystem

Medical Devices

Top Technologies

Polymerase Chain Reaction (PCR)
Magnetic Resonance Imaging (MRI)
Disposable Autoinjectors
Pulse Oximeters
Blood Pressure Monitors

Top Companies

Medtronic plc
Abbott Laboratories
Stryker Corporation
Becton, Dickinson and Company
JOHNSON & JOHNSON

Key Takeaways

South Korea's dental soft-tissue regeneration market is valued at $6.43 million in 2024 and will reach $10.24 million by 2029, growing at 9.8% CAGR.
South Korea's advanced healthcare system and high dental care awareness drive strong market adoption of regenerative periodontal treatments.
South Korea's aging demographic and rising periodontal disease prevalence create sustained demand for soft-tissue regeneration solutions.
South Korea's biotechnology expertise and medical device manufacturing leadership position it as a regional innovation center for dental regeneration.

Dental Soft-Tissue Regeneration Market Report Scope

Report Metric	Details
Base Year	2024
Fastest Growing Segment	PERIODONTOLOGY (Application)
Forecast Period	2024�2029
Growth Rate	CAGR of 7.8% from 2024 to 2029
Largest Segment	AUTOGRAFTS (Product Type)
Market Size Base Year (Billions)	~USD 0.34 (2024)
Revenue Forecast (Billions)	~USD 0.54 (2029)
Segments Covered	Product Type, Application, End User

South Korea Dental Soft-Tissue Regeneration Market Report Segmentation

3 segment dimensions are covered across the global market.

By Product Type

Autografts
Collagen-Based Membranes
Other Products
Synthetic Biomaterials

By Application

Implantology
Other Applications
Periodontology

By End User

Academic & Research Institutes
Dental Hospitals
Dsos & Independent Clinics

Target Audience

Dental Device Manufacturers : South Korean and international manufacturers need market-specific data to develop products aligned with local preferences, regulatory requirements, and the growing demand for regenerative periodontal solutions.
Healthcare Investment Firms : Private equity and venture capital investors targeting South Korea's healthcare sector require detailed market sizing, growth projections, and competitive analysis to identify high-return investment opportunities.
Dental Practice Operators : Dental clinics and periodontal specialists in South Korea need insights into market trends, patient demand patterns, and technology adoption rates to optimize service offerings and capital investments.
Pharmaceutical & Biotech Companies : Biotech firms developing regenerative materials and biologics require South Korea-specific market intelligence to guide R&D priorities, clinical trial planning, and commercialization timelines.
Healthcare Consultants & Advisors : Management consulting firms and healthcare advisors serving clients in South Korea need granular market data to support strategic planning, market entry strategies, and competitive positioning recommendations.

Key Companies in the South Korea Dental Soft-Tissue Regeneration Market

Company	HQ	Ownership	Strongest segments
HENRY SCHEIN, INC.	United States	Public Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
ENVISTA	United States	Public Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
ZIMVIE INC.	United States	Private Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
DENTSPLY SIRONA INC.	United States	Public Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
ABBVIE INC.	United States	Public Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
ADVANCED MEDICAL SOLUTIONS GROUP PLC	United Kingdom	Public Company	Collagen-based Membranes,Synthetic Biomaterials,Autografts,
TISSUE REGENIX	United Kingdom	Private Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
MECCELLIS BIOTECH	France		Collagen-based Membranes,Synthetic Biomaterials,Autografts,

HENRY SCHEIN, INC.

Henry Schein, Inc. is a publicly traded American company founded in 1932 with approximately 25,000 employees. It is a leading global distributor of dental, medical, and veterinary products and services.

ENVISTA

Envista is a publicly traded American company founded in 2018 with approximately 12,000 employees. The company operates as a global provider of dental products, technologies, and services.

ZIMVIE INC.

Zimvie Inc. is a privately held American company founded in 2021 with approximately 1,770 employees. The company focuses on dental implants, bone regeneration, and related surgical solutions.

DENTSPLY SIRONA INC.

Dentsply Sirona Inc. is a publicly traded American company founded in 2015. The company is a leading manufacturer and distributor of dental products, technologies, and equipment.

ABBVIE INC.

AbbVie Inc. is a publicly traded American pharmaceutical company founded in 2012 with approximately 57,000 employees. The company develops and markets a broad range of pharmaceutical products across multiple therapeutic areas.

ADVANCED MEDICAL SOLUTIONS GROUP PLC

Advanced Medical Solutions Group PLC is a publicly traded British company founded in 1991 with approximately 1,800 employees. The company specializes in advanced wound care and surgical solutions.

TISSUE REGENIX

Tissue Regenix is a privately held British company founded in 2006 with approximately 92 employees. The company develops regenerative medicine and advanced wound care products.

MECCELLIS BIOTECH

Meccellis Biotech is a French company founded in 2011 that operates in the biotechnology sector. The company focuses on regenerative medicine and cellular therapy solutions.

Reasons to Buy this Report

Market-Specific Growth Intelligence : Gain detailed insights into South Korea's 9.8% CAGR trajectory and understand the unique drivers differentiating this market from global trends and competing Asian markets.
Demographic & Consumer Insights : Access comprehensive analysis of South Korea's aging population dynamics and their specific preferences for minimally invasive periodontal solutions to inform product development strategies.
Competitive Landscape Analysis : Identify key players, market consolidation patterns, and competitive positioning specific to South Korea's dental soft-tissue regeneration sector for strategic market entry planning.
Regulatory & Healthcare Framework : Understand South Korea's unique regulatory environment, reimbursement policies, and healthcare infrastructure to navigate market entry and optimize commercialization strategies effectively.
Investment & Expansion Opportunities : Discover high-potential segments, partnership opportunities, and expansion pathways within South Korea's growing market to maximize ROI and establish regional market leadership.

Frequently asked questions

What is the current market size of dental soft-tissue regeneration in South Korea?

South Korea's dental soft-tissue regeneration market was valued at $6.43 million in 2024 and is projected to grow to $10.24 million by 2029.

What is the expected growth rate for South Korea's dental soft-tissue regeneration market?

South Korea's market is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2029.

What factors are driving growth in South Korea's dental soft-tissue regeneration market?

South Korea's market growth is driven by an aging population, increasing periodontal disease prevalence, advanced healthcare infrastructure, high dental care awareness, and strong biotechnology innovation capabilities.

How does South Korea's market compare to the global dental soft-tissue regeneration market?

South Korea's 9.8% CAGR outpaces the global market growth rate of 7.8%, reflecting stronger regional demand and healthcare investment in regenerative dental solutions.

What role does South Korea play in the Asia Pacific dental regeneration market?

South Korea is emerging as a key Asia Pacific hub for dental soft-tissue regeneration, leveraging its medical device manufacturing expertise, clinical research capabilities, and high adoption rates of advanced periodontal treatments.

RESEARCH METHODOLOGY

This study involved four key activities to estimate the current size of the dental soft-tissue regeneration market. First, extensive secondary research was conducted to gather information about the market, as well as related markets and the overall parent market. Next, the findings, assumptions, and estimates were validated through primary research conducted with industry experts across the value chain. Both top-down and bottom-up approaches were utilized to determine the overall market size. Finally, market breakdown and data triangulation techniques were employed to estimate the sizes of various segments and subsegments.

Secondary Research

The secondary research process utilized a variety of sources, including directories and databases such as Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company documents, investor presentations, and SEC filings. This method was employed to gather information relevant to a comprehensive, technical, market-focused, and commercial analysis of the dental soft-tissue regeneration market. It also helped obtain crucial details about key players in the industry, market classification, and segmentation based on current trends, extending down to the most granular levels. Additionally, important developments related to market and technological perspectives were captured. A database of key industry leaders was created using the information collected through secondary research.

Primary Research

In the primary research process, a variety of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from important companies and organizations operating in the dental soft-tissue regeneration market. On the demand side, primary sources consisted of industry experts, purchasing and sales managers, doctors, and personnel from research organizations. This primary research aimed to validate market segmentation, identify key players, and collect insights on major industry trends and market dynamics.

A breakdown of the primary respondents for the dental soft-tissue regeneration market is provided below:

Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.

Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global dental soft-tissue regeneration market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global dental soft-tissue regeneration market was split into various segments and subsegments based on:

List of major players operating in the products market at the regional and/or country level
Product mapping of various dental soft-tissue regeneration manufacturers at the regional and/or country level
Mapping of annual revenue generated by listed major players from dental soft-tissue regenerative products (or the nearest reported business unit/product category)
Revenue mapping of major players to cover at least 70–75% of the global market share as of 2023
Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
Summation of the market value of all segments/subsegments to arrive at the global diagnostics market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Market Size Estimation (Bottom-up Approach & Top-down Approach)

Data Triangulation

After arriving at the overall size of the global dental soft-tissue regeneration market through the above-mentioned methodology, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.

Market Definition

Dental soft-tissue regeneration involves restoring or reconstructing soft tissues, including the gums and connective tissues surrounding the teeth. This process seeks to facilitate the healing of tissues lost due to gum disease or trauma to enhance the health and aesthetic appearance of the gums and their functionality. These procedures can be effectively used in the treatment of gum recession, tissue defects around the implants, or any other soft-tissue defects, and eventually, to improve the smile.

Stakeholders

Dental soft-tissue regenerative material manufacturing companies
Distributors and suppliers of dental soft-tissue regeneration products
Medical device companies
Research and consulting firms
Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
Research institutes and academic centers
Contract research organizations (CROs)
Government associations
Venture capitalists and investors

Report Objectives

To define, describe, and forecast the dental soft-tissue regeneration market based on product type, application, end user, and region
To forecast the market size based on six key regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, Porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events
To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall dental soft-tissue regeneration market
To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
To strategically profile key players in the dental soft-tissue regeneration market and comprehensively analyze their core competencies
To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall dental soft-tissue regeneration market
To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
To analyze the generative AI impact on the dental soft-tissue regeneration market

Get the Full Dental Soft-Tissue Regeneration Market Report

Full forecast, segment splits, and company analysis for all Dental Soft-Tissue Regeneration Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)